DJIA 18,053.71 23.50 0.13%
NASDAQ 4,806.86 33.39 0.70%
S&P 500 2,088.77 6.89 0.33%
market minute promo

Roche Holding Ltd. (ADR) (NASDAQOTH: RHHBY)

34.23 -0.06 (-0.16%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

RHHBY $34.23 -0.16%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $34.29
Previous Close $34.28
Daily Range $34.20 - $34.35
52-Week Range $33.23 - $38.71
Market Cap $24.0B
P/E Ratio 0.00
Dividend (Yield) $0.00 (2.7%)
Volume 2,045,154
Average Daily Volume 1,268,459
Current FY EPS $1.95

Sector

Healthcare

Industry

Pharmaceuticals

Roche Holding Ltd. (ADR) (RHHBY) Description

Website:

News & Commentary

3 Value Stocks Near 52-Week Lows Worth Buying

These three value stocks have been beaten up recently, but there's a chance they may not stay near their 52-week lows for much longer.

3 Biotech Stocks I Don't Want for Christmas

I’d prefer coal in my stocking to these three troubled biotech stocks.

The Most Disappointing Clinical Failures in 2014

Three Motley Fool contributors tell us what they think were the biggest drug trial failures this year.

Why ImmunoGen Inc. Stock Was Throttled

ImmunoGen shares lose half their value following an update on a key breast cancer drug trial. Find out whether today's swoon could mark a buying opportunity.

3 Beaten Down Stocks Ready to Bounce Back

Not all stocks had a great 2014. Here are three stocks that could be ready for a comeback.

This Growing Concern Accounts For Nearly 500,000 Cancer Cases Each Year

A recent World Health Organization study shows that this growing problem is responsible for nearly a half-million cancer diagnoses each year.

This is Incredibly Good News for Breast Cancer Survivors

A recently released study from Canada shines light on the advancements made in treating breast cancer over the past two decades.

Why Inovio Pharmaceuticals Inc. Stock Plunged 15% in November

Inovio Pharmaceuticals stock dips by double-digits in November after the company witnesses a key licensing deal with a major pharmaceutical company come to an end.

This High-Yield Dividend Stock Screams Danger

This high-yield dividend stock may be paying out north of 7%, but its long-term outlook might have investors wisely running in the opposite direction.

Why Shareholders of Organovo Holdings Inc Have Been Waiting For This Day

This 3D bioprinting company finally has a product on the market.

See More RHHBY News...

RHHBY's Top Competitors

RHHBY $34.23 (-0.16%)
Current stock: RHHBY
JNJ $105.06 (0.45%)
Current stock: JNJ
PFE $31.65 (0.73%)
Current stock: PFE
GSK $43.15 (0.70%)
Current stock: GSK